- Home
- Publications
- Publication Search
- Publication Details
Title
CCR5 status and metastatic progression in colorectal cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 8, Issue 9, Pages e1626193
Publisher
Informa UK Limited
Online
2019-07-13
DOI
10.1080/2162402x.2019.1626193
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5
- (2019) Gen Nishikawa et al. Cell Death & Disease
- Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
- (2019) Jakob Nikolas Kather et al. BRITISH JOURNAL OF CANCER
- Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
- (2018) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
- (2018) Santosh Kumar Singh et al. Scientific Reports
- Topography of cancer-associated immune cells in human solid tumors
- (2018) Jakob Nikolas Kather et al. eLife
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
- (2016) Niels Halama et al. CANCER CELL
- CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV
- (2016) Michelle B. Kim et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tumour-associated and non-tumour-associated microbiota in colorectal cancer
- (2016) Burkhardt Flemer et al. GUT
- Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis
- (2016) Ying Wang et al. ONCOLOGY REPORTS
- Evolution of coreceptor utilization to escape CCR5 antagonist therapy
- (2016) Jie Zhang et al. VIROLOGY
- Unknown
- (2016) Oncotarget
- Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5
- (2016) Vittoria D'Esposito et al. Oncotarget
- CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells
- (2016) Darrin Gao et al. Open Biology
- Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs
- (2016) E. C. Halvorsen et al. OncoImmunology
- Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32
- (2015) Timothy J. Henrich et al. AIDS
- Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
- (2015) Erik Tanis et al. EUROPEAN JOURNAL OF CANCER
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
- (2015) Haixia Long et al. Oncotarget
- Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
- (2015) Guido Kroemer et al. OncoImmunology
- CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines
- (2014) D. Sicoli et al. CANCER RESEARCH
- CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination
- (2014) Andrea Mencarelli et al. Translational Oncology
- CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects
- (2014) Houqun Ying et al. TUMOR BIOLOGY
- Improving outcomes in colorectal cancer: Where do we go from here?
- (2013) Eric Van Cutsem et al. EUROPEAN JOURNAL OF CANCER
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
- (2012) H. Thorvaldsdottir et al. BRIEFINGS IN BIOINFORMATICS
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
- (2012) M. Velasco-Velazquez et al. CANCER RESEARCH
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma
- (2011) Béatrice Cambien et al. PLoS One
- The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
- (2011) Gabriela Bindea et al. Seminars in Immunopathology
- Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration
- (2010) Tim Zimmermann et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
- (2009) Luigi Dolcetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The biology of CCR5 and CXCR4
- (2009) Ghalib Alkhatib Current Opinion in HIV and AIDS
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started